Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Arqit Quantum Inc (ARQQ) vs Centene Corp (CNC) Price & Performance

Arqit Quantum IncTrade
Centene CorpTrade

Price performance (Past 24H)

Key statistics

Arqit Quantum Inc vs Centene Corp — how do they compare? Arqit Quantum Inc trades at $18.11 (market cap $332.04M), while Centene Corp trades at $68.45 (market cap $33.26B). The key difference: Centene Corp is far larger — about 100.2× Arqit Quantum Inc's market cap, and Centene Corp is trading nearer its 52-week high, Arqit Quantum Inc nearer its low. Which is the better fit depends on your goals.

ARQQCNC
Market Cap
$332.04M$33.26B
Sector
TechnologyHealth
52-Week High
$58.27$68.34
52-Week Low
$11.78$25.21
Enterprise Value
$305.35M$25.89B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Arqit Quantum Inc

ARQQ trades at $19.08, down 6.79% today, with a bearish technical signal from moving averages. The company reported $530K revenue for 2025 but a net loss of $35.34M, with negative profit margins and high valuation ratios. Recent news highlights contract wins and 829% YoY revenue growth in H1 FY26, though earnings misses persist.

Outlook remains speculative given deep losses and high P/S of 275.84, but growth in quantum security deals offers potential. Key risks include cash burn and competitive threats. Analyst consensus is split 50/50 buy/hold, indicating cautious optimism amid fundamental challenges.

Centene Corp

Centene (CNC) trades at $67.35, down 0.37% on the day, with a bullish technical signal from moving averages. The stock shows attractive valuation ratios, including a P/E of 8.06 and P/S of 0.17, but faces profitability challenges with a negative net income margin of -3.25% for 2025. Recent positive developments include the renewal of a key Illinois Medicaid contract and consistent earnings beats in recent quarters, supporting a strong analyst consensus with 61% buy ratings.

The outlook for CNC hinges on successful margin recovery initiatives and cost management. Investment opportunities lie in its undervalued metrics and stable revenue base, but risks include persistent negative profitability, regulatory pressures in healthcare, and execution challenges in improving medical cost controls. The consensus price target of $63.36 suggests limited near-term upside from current levels.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Arqit Quantum Inc

Arqit Quantum provides advanced cybersecurity software that uses symmetric key agreement technology. Its solutions protect networked devices and data against current and future cyber threats, including quantum attacks.

Read more on ARQQ

About Centene Corp

Centene is a managed-care organization focused on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of September 2021, mostly in Medicaid (68% of membership), the individual exchanges (10%), Medicare Advantage (6%), and the balance in Tricare (West region), correctional facility, and international plans. The company also serves 4 million users through the Medicare Part D pharmaceutical program.

Read more on CNC